Outstanding Achievement Award
About the Award
The ASGCT Outstanding Achievement Award recognizes an ASGCT member who has achieved a pioneering research success, specific high-impact accomplishment, or lifetime of significant contributions to the field of gene and cell therapy. It is the Society’s highest honor and the recipient is celebrated at the ASGCT Annual Meeting. The recipient presents a plenary lecture highlighting their scientific accomplishments that led to the award.
Criteria and Nominations
Any ASGCT member, other than a current officer or member of the Nomination and Awards Committee, is eligible. Nomination letters must be 500 words or fewer and be submitted by two ASGCT members. Nominees will be notified and required to provide a CV or NIH bio-sketch.
Nominate yourself or a colleague through September 16! Send nominations letters to awards@asgct.org.
Recipients
2025
Jeff Chamberlain, PhD
2024
David Liu, PhD
Continuous Evolution of Genome Editing Systems for Targeted Gene-Sized DNA Integration in Mammalian Cells
2023
J. Keith Joung, MD, PhD
Gene Editing Voyages from Z to C (Zinc fingers to CRISPR)
2022
Donald Kohn, MD
Hematopoietic Stem Cell Gene Therapy for SCID
2021
Carl June, MD, and Michel Sadelain, MD, PhD
2020
Mavis Agbandje-McKenna, PhD
Structure-guided AAV Vectorology
2019
John J. Rossi, PhD, Beckman Research Institute City of Hope, Duarte CA
My 40-Year Journey to Develop RNA Base Therapies
2018
Jean Bennett, MD, PhD, University of Pennsylvania, Philidelphia, PA
Seeing the Light with Retinal Gene Therapy: From Fantasy to Reality
2017
Maria-Grazia Roncarolo, MD, Stanford University School of Medicine, Stanford, CA
Cell and Gene Therapy for Genetic Immunodeficiencies: Popping the Bubble
2016
Seppo Yla-Herttuala, MD, PhD, FESC, University of Eastern Finland
Vascular Biology and Advances in Cardiovscular and Cancer Gene Therapy From Bench to Bedside
2015
Bruce Sullenger, PhD, Duke University Medical Center, Durham, NC
Therapeutic Aptamers from HIV Gene Therapy to the Cath Lab and Cancer
2014
Luigi Naldini, MD, PhD, University Vita-Salute San Raffaele
Lentiviral Vectors From Bench to Bedside: A Lifetime Journey
2013
Mark A. Kay, MD, PhD, Stanford University School of Medicine
Deciphering Vector and Non-coding RNA Biology: A New Frontier in Nucleic Acid based Therapies.
2012
David A. Williams, MD, Children's Hospital Boston, Boston, MA
25 Years in Translation: The Hematopoietic Microenvironment and HSC Gene Therapy
2011
Malcolm K. Brenner, MD, PhD, Baylor College of Medicine, Houston, TX
Cell and Gene Therapy - Putting it Together
2010
Katherine A. High, MD, The Children’s Hospital of Philadelphia, Philadelphia, PA
Gene Therapy for Genetic Disease: Hemophilia as a Paradigm
2009
Inder Verma, PhD, The Salk Institute, La Jolla, CA
25 Years of Gene Therapy: Ups and Downs
2008
R. Jude Samulski, PhD, University of North Carolina at Chapel Hill, Chapel Hill, NC
AAVolution of a Smart Virus